During the recent session, Bausch Health Companies Inc (NYSE:BHC)’s traded shares were 2.73 million, with the beta value of the company hitting 0.76. At the last check today, the stock’s price was $9.11, reflecting an intraday gain of 11.57% or $0.94. The 52-week high for the BHC share is $11.46, that puts it down -25.8 from that peak though still a striking 56.53% gain since the share price plummeted to a 52-week low of $3.96. The company’s market capitalization is $4.66B, and the average intraday trading volume over the past 10 days was 1.29 million shares, and the average trade volume was 2.13 million shares over the past three months.
Bausch Health Companies Inc (BHC) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 3.12. BHC has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 1.09.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bausch Health Companies Inc (NYSE:BHC) trade information
Bausch Health Companies Inc (BHC) registered a 11.57% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 11.57% in intraday trading to $9.11, hitting a weekly high. The stock’s 5-day price performance is 12.25%, and it has moved by 11.70% in 30 days. Based on these gigs, the overall price performance for the year is 33.65%. The short interest in Bausch Health Companies Inc (NYSE:BHC) is 12.03 million shares and it means that shorts have 5.17 day(s) to cover.
The consensus price target of analysts on Wall Street is $9, which implies a decrease of -1.22% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7 and $16 respectively. As a result, BHC is trading at a discount of -75.63% off the target high and 23.16% off the low.
Bausch Health Companies Inc (BHC) estimates and forecasts
Statistics show that Bausch Health Companies Inc has underperformed its competitors in share price, compared to the industry in which it operates. Bausch Health Companies Inc (BHC) shares have gone up 12.67% during the last six months, with a year-to-date growth rate less than the industry average at 3.15% against 21.40. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -5.20% this quarter and then jump 31.70% in the quarter after that. In the rating firms’ projections, revenue will increase 8.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 2.51B as predicted by 7 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to 2.25B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 2.41B and 2.15B respectively. In this case, analysts expect current quarter sales to grow by 4.20% and then jump by 4.40% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 32.76%. While earnings are projected to return 7.02% in 2024, the next five years will return 4.44% per annum.
BHC Dividends
Bausch Health Companies Inc is due to release its next quarterly earnings on 2025-Feb-20. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. The average dividend yield of the company for the last 5 years is 6.52%.
Bausch Health Companies Inc (NYSE:BHC)’s Major holders
Bausch Health Companies Inc insiders own 11.28% of total outstanding shares while institutional holders control 78.95%, with the float percentage being 88.99%. ICAHN CARL C is the largest shareholder of the company, while 311.0 institutions own stock in it. As of 2024-06-30, the company held over 34.72 million shares (or 9.466% of all shares), a total value of $242.01 million in shares.
The next largest institutional holding, with 26.44 million shares, is of PAULSON & CO. INC.’s that is approximately 7.208% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $184.28 million.
